INVION LIMITED — Major Shareholding Notification 2011

Jan 30, 2011

604 page 2/2 15 July 2001

Form 604 Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme

CBio Limited

ACN/ARSN

094 730 417

1. Details of substantial holder (1)

Name DR MICHAEL MONSOUR ACN/ARSN (if applicable)

There was a change in the interests of the substantial holder on 25/01/2011 The previous notice was given to the company on 02/12/2010 The previous notice was dated 03/12/2010

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4)	Previous notice	Previous notice	Present notice	Present notice
	Person’s votes	Voting power(5)	Person’s votes	Voting power(5)
Ordinary	9,746,407	8%	9,746,407	7%

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of change	Person whose relevant interest changed	Nature of change (6)	Consideration given in relation to change (7)	Class and number of securities affected	Person’s votes affected
25/01/11	MPAMM PTY LTD	OFF-MARKET PURCHASE OF 156,250 SHARES & OFF MARKET DISPOSAL OF 156,250 SHARES AT ASX DIRECTION	Net nil	156,250 ORDINARY SHARES	156,250
25/01/11	MP MONSOUR MEDICAL PRACTICE PTY LTD	OFF-MARKET PURCHASE OF 978,219 SHARES & OFF MARKET DISPOSAL OF 978,219 SHARES AT ASX DIRECTION	Net nil	978,219 ORDINARY SHARES	978,219

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Nature of relevant interest (6)	Class and number of securities	Person’s votes
DR MICHAEL MONSOUR	DR MICHAEL MONSOUR	DR MICHAEL MONSOUR	BENEFCIAL OWENER	65,464 ORDINARY SHARES	65,464
DR MICHAEL MONSOUR	MP MONSOUR MEDICAL PRACTICE PTY LTD	MP MONSOUR MEDICAL PRACTICE PTY LTD	DIRECTOR & SHAREHOLDER	2,785,848 ORDINARY SHARES	1,807,629
DR MICHAEL MONSOUR	MPAMM PTY LTD	MPAMM PTY LTD	DIRECTOR & SHAREHOLDER	7,540,691 ORDINARY SHARES	7,384,441

	DR MICHAEL MONSOUR	AUSTRALIAN TECHNOLOGY INNOVATION FUND LTD	AUSTRALIAN TECHNOLOGY INNOVATION FUND LTD	DIRECTOR & SHAREHOLDER	368,755 ORDINARY SHARES	289,118
	DR MICHAEL MONSOUR	AUSTRALIAN BIOFUNDS INVESTMENTS LIMITED	AUSTRALIAN BIOFUNDS INVESTMENTS LIMITED	DIRECTOR & SHAREHOLDER	199,755 ORDINARY SHARES	199,755
5. Changes in association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable) Nature of association 6. Addresses The addresses of persons named in this form are as follows: Name Address DR MICHAEL MONSOUR 297 KENT ST MARYBOROUGH QLD 4065 MPAMM PTY LTD 297 KENT ST MARYBOROUGH QLD 4065 MP MONSOUR MEDICAL PRACTICE PTY LTD 297 KENT ST MARYBOROUGH QLD 4065 AUSTRALIAN TECHNOLOGY INNOVATION FUND LIMITED 85 BRANDL ST EIGHT MILE PLAINS QLD 4113 AUSTRALIAN BIOFUNDS INVESTMENTSLIMITED PO BOX 3104 SOUTH BRISBANE QLD 4101 Signature print name DR MICHAEL MONSOUR capacity sign here date 31/01/2011 DIRECTIONS (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form. (2) See the definition of "associate" in section 9 of the Corporations Act 2001. (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. (4) The voting shares of a company constitute one class unless divided into separate classes. (5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100. (6) Include details of:
(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies). See the definition of "relevant agreement" in section 9 of the Corporations Act 2001. (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

• (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

• See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

• (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

604 GUIDE page 1/1 13 March 2000

GUIDE

This guide does not form part of the prescribed form and is included by ASIC to assist you in completing and lodging form 604.

==> picture [521 x 208] intentionally omitted <==

----- Start of picture text -----

Signature This form must be signed by either a director or a secretary of the substantial holder.
Lodging period Nil
Lodging Fee Nil
Other forms to be
Nil
completed
Additional information (a) If additional space is required to complete a question, the information may be included on a separate piece of
paper annexed to the form.
----- End of picture text -----

• (b) This notice must be given to a listed company, or the responsible entity for a listed managed investment scheme. A copy of this notice must also be given to each relevant securities exchange.

(c) The person must give a copy of this notice:

• (i) within 2 business days after they become aware of the information; or

• (ii) by 9.30 am on the next trading day of the relevant securities exchange after they become aware of the information if:

• (A) a takeover bid is made for voting shares in the company or voting interests in the scheme; and

• (B) the person becomes aware of the information during the bid period.

Annexures

To make any annexure conform to the regulations, you must

• 1 use A4 size paper of white or light pastel colour with a margin of at least 10mm on all sides

• 2 show the corporation name and A.C.N or ARBN

• 3 number the pages consecutively

• 4 print or type in BLOCK letters in dark blue or black ink so that the document is clearly legible when photocopied

• 5 identify the annexure with a mark such as A, B, C, etc

• 6 endorse the annexure with the words:

• This is annexure (mark) of (number) pages referred to in form (form number and title)

• 7 sign and date the annexure.

The annexure must be signed by the same person(s) who signed the form.

Information in this guide is intended as a guide only. Please consult your accountant or solicitor for further advice.